An annual event focused on recent developments in kidney disease prevention and treatment
Orlando Florida, March 2, 2019 — The National Kidney Foundation of Florida, Inc. and Alessia Fornoni, M.D. Ph.D., Professor and Chief, Division of Nephrology and Hypertension, The University of Miami Miller School of Medicine were proud to present this year’s John E. Cunio, M.D. and John R. Richardson, Jr.,M.D. Memorial Lecture, an annual event focused on new developments in the prevention and treatment of kidney disease. All members of the medical community are invited to attend. The 2018 Cunio Lecture formally took place on August 31st of last year.
About the John E. Cunio, M.D. and John R. Richardson, Jr., M.D. Memorial Lecture
Dr. Richardson was a pioneer nephrologist in Miami. Trained at Emory and the U, his first mentor was Wm. Hulet, a trainee of Homer Smith. His ascendant career was cut short by colon cancer, leaving community of patients and colleagues who chose to honor his memory with a lectureship.
Dr. John Cunio was a Miami native and member of the second class in the the new U. of Miami Medical School, was likewise a much loved member of the nephrologic and medical community when he died shortly after his retirement. A lectureship in his honor was funded spontaneously. The two lectureships, which are administered by the National Kidney Foundation of Florida, were combined and continue to remind us of two unique physicians.
The 2018 Conference was led by guest lecturer, Oliver Gross, M.D.Dr. Gross is recognized as a leader inthe field of type IV collagen diseasesand collagen receptors with numerous original articles on potential therapies of extracellular matrix diseases such as Alport syndrome, including studies of murine type IV collagen knockouts and different collagen receptors knockout mice. Dr. Gross is Professor of Internal Medicine at University of Goettingen, and head attending Nephrologist. He is board certified in Internal Medicine and Nephrology. He has been a member of
the faculty of the University of Goettingen since 2006. He is a Fellow of the American Society of Nephrology. He founded the European Alport Registry. He is Initiator and Coordinating Principal Investigator of the world’s first clinical trial in children with Alport syndrome EARLY PRO-TECT Alport. Dr. Gross has authored numerous original research articles, reviews and book chapters on extracellular matrix and type IV collagen diseases.
He has lectured on these topics at numerous institutions and meetings, both nationally and internationally.
Dr. Gross is (co-)author of all international treatment recommendations and research strategies in Alport’s as he was the first to initiate and lead an interventional clinical trial in children with Alport syndrome.
The National Kidney Foundation (NKF) is the largest, most comprehensive and longstanding organization dedicated to the awareness, prevention and treatment of kidney disease. For more information about NKF visit www.kidney.org.